TBC1D9, also known as MDR1 (multidrug resistance 1), is a P-glycoprotein implicated in the mechanism of multidrug resistance to chemotherapeutic agents. TBC1D9 functions as an energy-dependent membrane efflux pump for lipophilic compounds.
Alternative names for
MDR1/TBC1D9 Antibody include TBC1D9 antibody,
TBC1 domain family member 9 antibody,
TBC1 domain family member 9A antibody,
TBC1 domain family, member 9with GRAM domain) antibody.